4
Changes in Ownership
Alkermes plc. Filed Acc 0001127602-22-005455
EVP R&D, Chief Medical Officer gave up 1,069 shares (to pay taxes)
- EVP R&D, Chief Medical Officer acquired 3,375 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2022-02-16 | Option exercise | +3,375 | 12,871 | D | ||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2022-02-16 | Shares withheld for taxes | −1,069 | $26.79 | $28,639 | 11,802 | D |
| Derivatives | |||||||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2022-02-16 | Option exercise · Restricted Stock Unit Award | −3,375 | 0 | D | ||
Loading xslF345X03/form4.xml…